EQS-News

Bellevue Asset Management AG: A straightforward idea leads to solid outperformance - the Adamant Global Healthcare Index celebrates its 10-year anniversary

EQS Group-News: Bellevue Asset Management AG / Key word(s): Funds Bellevue Asset Management AG: A straightforward idea leads to solid outperformance - the Adamant Global Healthcare Index celebrates its 10-year anniversary 31.05.2017 / 08:41 Media Release of May 31, 2017

A straightforward idea leads to solid outperformance - the Adamant Global Healthcare Index celebrates its 10-year anniversary

 

The idea behind the launch of the Adamant Global Healthcare Index in April 2007 was simplistic and successful. Investors should focus more on mid-cap stocks rather than the somewhat unwieldy large caps and deviate from conventional benchmarks that place a disproportionate emphasis on pharma compared to other sub-sectors in the healthcare universe. "We wanted to give our clients access to the diverse range of investment opportunities that the healthcare sector offers. Pharma stocks currently account for less than 10% of our portfolio. Even from a historical perspective, pharma has always been heavily underweighted in the index, while other healthcare sub-sectors such as medtech, services, generics and biotech have been overweighted. That approach has served us very well over the past ten years," says Dr. Cyrill Zimmermann, Head Healthcare Funds & Mandates at Bellevue Asset Management.

From an index to a fund

Since inception, the index has produced an excess return of 189% relative to the MSCI World Index and of 125% relative to the MSCI World Health Care Index. The absolute performance since its launch is 234% (in USD). The success of the Adamant Healthcare Index led to the 2011 launch of a Swiss investment fund for institutional investors that replicates the index. This Swiss fund was followed by the launch of a similar Luxembourg-based fund product in October 2016. The BB Adamant Healthcare Index (Lux) Fund (ISIN B-USD LU1477742909) is registered for public distribution in Germany, Austria, Switzerland and Luxembourg. A total of CHF 190 mn is invested according to this proprietary index methodology.